Gujarat Pharmaceutical Industry Confronts Severe Cost Pressures Amid Raw Material Price Surge
Pharmaceutical manufacturers in Gujarat are grappling with escalating cost pressures as prices of critical raw materials have surged dramatically over the past month. This sharp increase is primarily driven by supply disruptions stemming from the ongoing conflict in West Asia, severely impacting the financial stability of drug makers across the state.
Steep Price Hikes in Active Pharmaceutical Ingredients (APIs)
Industry sources report that prices of several petrochemical-based Active Pharmaceutical Ingredients (APIs) have risen steeply, with some cases witnessing increases as high as 90%. This surge is severely squeezing profit margins for pharmaceutical companies, particularly those manufacturing essential medicines where selling prices are tightly regulated by government caps.
Among the most affected inputs, metformin has recorded a price increase of nearly 90%, paracetamol by around 50%, and sodium acid citrate BP by 31% within just one month. These drastic hikes have disrupted cost calculations industry-wide, forcing companies to reassess and adjust their production strategies to cope with the financial strain.
Broad Impact Beyond APIs
The cost pressure extends well beyond APIs. Prices of excipients, solvents, intermediates, and even packaging materials have also climbed significantly, compounding the burden on manufacturers. Adding to the uncertainty, suppliers are reportedly unwilling to hold quotations for more than an hour due to extreme price volatility in the market.
"There is unprecedented uncertainty in the raw material market. API suppliers are not willing to commit to rates, and that has created enormous financial stress for manufacturers who need predictable input costs," said Munjal Patel, director of Lincoln Pharmaceuticals Ltd.
Supply Constraints and Economic Factors
Supply constraints have further tightened the availability of several APIs, with disruptions in gas supplies affecting the production of petrochemical-linked materials. The situation has been exacerbated by a weakening rupee, which has made imported raw materials more expensive, adding another layer of financial pressure on the industry.
Industry experts note that manufacturers of scheduled drugs are facing the greatest strain, as they are unable to pass on rising costs to consumers due to strict price caps imposed by regulatory authorities.
Logistics Challenges and Export Disruptions
Highlighting the logistics challenges, Viranchi Shah, former national president of the Indian Drug Manufacturers' Association, pointed out that disruptions in vessel movement along India's western coast are affecting both exports and input supplies.
"There is disruption due to availability of vessels sailing to and from the western shore of India, which poses a challenge for pharma exporters. Most players anticipate supply chain issues in petrochemical-based APIs, KSMs, and solvents. This has led to speculative increases in API rates, though we expect the situation to stabilise soon," he said.
The combination of geopolitical tensions, supply chain disruptions, and economic factors has created a perfect storm for Gujarat's pharmaceutical sector, prompting urgent calls for strategic adjustments and potential policy interventions to mitigate the ongoing crisis.
